• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 436476 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413809766 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413809766 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Ariad Pharmaceuticals Bullish Moving Average Crossover Alert (ARIA)

Published on Tue, 02/05/2013 - 12:15
By Robert Cotter

Today, shares of Ariad Pharmaceuticals (NASDAQ:ARIA) have crossed bullishly above their 10-day moving average of $19.88 on a volume of 480K shares. Swing traders may find an opportunity for a long position, as such a crossover often suggests higher prices in the near term.

ARIAD Pharmaceuticals, Inc. discovers and develops breakthrough medicines that regulate cell signaling with small molecules. The Company is primarily focused on product candidates for targeted indications. ARIAD is developing products to treat solid tumors, to block the spread of cancer, to treat certain forms of leukemia, and to treat cancer that has spread to bone and primary bone cancers.

In the past 52 weeks, Ariad Pharmaceuticals share prices have been bracketed by a low of $13.92 and a high of $25.40 and are now at $20.19, 45% above that low price. The 200-day and 50-day moving averages have moved 0.39% higher and 0.35% lower over the past week, respectively.

Ariad Pharmaceuticals has overhead space with shares priced $20.19, or 28.4% below the average consensus analyst price target of $28.20. The stock should hit resistance at its 50-day moving average (MA) of $20.68, as well as support at its 200-day MA of $19.77.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Photronics Underperformed its ...

Below are five companies in the Semiconductor Equipment industry that underperformed ye ...

Analysis of Relative Performance in the ...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...

Shares of Krispy Kreme Doughnuts Underpe...

Below are five companies in the Restaurants industry that underperformed yesterday on a ...

Bottom 5 Companies in the Residential RE...

Here are 5 stocks in the Residential REITs industry ranked by performance. We compiled ...

Shares of M&T Bank Underperformed its Pe...

Analysis was conducted on the Regional Banks industry to measure relative performance t ...

Shares of MBIA Underperformed its Peers ...

Below are five companies in the Property & Casualty Insurance industry that underperfor ...

Shares of First Majestic Silver Underper...

Here are 5 stocks in the Precious Metals & Minerals industry ranked by performance. We ...

Bottom 5 Companies in the Personal Produ...

Analysis was conducted on the Personal Products industry to measure relative performanc ...